The Preuss Foundation Seminar on vaccine therapy for malignant primary brain tumors. February 15-17, 1998, La Jolla, Calif.
Sampson
J H
JH
Duke University Medical Center, Division of Neurosurgery, Box 3807, 4505 Busse Bldg., Durham, NC 27710, USA.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000276:immunology; D001254:Astrocytoma / Q000276:immunology / Q000628:therapy; D020274:Autoimmune Diseases of the Nervous System / Q000209:etiology; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D019496:Cancer Vaccines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use* / Q000633:toxicity; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D016207:Cytokines / Q000627:therapeutic use; D003713:Dendritic Cells / Q000276:immunology; D006040:Goals; D006801:Humans; D016867:Immunocompromised Host; D016233:Immunotherapy, Active / Q000009:adverse effects; D008546:Melanoma, Experimental / Q000276:immunology / Q000628:therapy; D051379:Mice; D014411:Neoplastic Stem Cells / Q000276:immunology; D020721:Nervous System Autoimmune Disease, Experimental / Q000209:etiology; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D014407:Tumor Cells, Cultured / Q000276:immunology
D000888:Antibodies, Anti-Idiotypic; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D016207:Cytokines